Report Detail

Medical Industry Global Genetic Carrier Screening Service Market Growth (Status and Outlook) 2023-2029

  • RnM4515163
  • |
  • 22 February, 2023
  • |
  • Global
  • |
  • 100 Pages
  • |
  • LPI(LP Information)
  • |
  • Medical Industry

The global Genetic Carrier Screening Service market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Genetic Carrier Screening Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Genetic Carrier Screening Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Genetic Carrier Screening Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Genetic Carrier Screening Service players cover Clinical Labs, Eurofins Scientific, Fulgent Genetics, Gene by Gene, Illumina, Invitae, MedGenome Labs, My Baby Company and Myriad Genetics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Genetic Carrier Screening Service Industry Forecast” looks at past sales and reviews total world Genetic Carrier Screening Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Genetic Carrier Screening Service sales for 2023 through 2029. With Genetic Carrier Screening Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetic Carrier Screening Service industry.

This Insight Report provides a comprehensive analysis of the global Genetic Carrier Screening Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genetic Carrier Screening Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genetic Carrier Screening Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Carrier Screening Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Carrier Screening Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Carrier Screening Service market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
Expanded Carrier Screening Service
Targeted Disease Carrier Screening Service

Segmentation by application
Pregnant Woman
Couple

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Clinical Labs
Eurofins Scientific
Fulgent Genetics
Gene by Gene
Illumina
Invitae
MedGenome Labs
My Baby Company
Myriad Genetics
Natera
NxGen MDx, LLC
OPKO Health
Thermo Fisher Scientific
Sonic Genetics


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Genetic Carrier Screening Service Market Size 2018-2029
    • 2.1.2 Genetic Carrier Screening Service Market Size CAGR by Region 2018 VS 2022 VS 2029
  • 2.2 Genetic Carrier Screening Service Segment by Type
    • 2.2.1 Expanded Carrier Screening Service
    • 2.2.2 Targeted Disease Carrier Screening Service
  • 2.3 Genetic Carrier Screening Service Market Size by Type
    • 2.3.1 Genetic Carrier Screening Service Market Size CAGR by Type (2018 VS 2022 VS 2029)
    • 2.3.2 Global Genetic Carrier Screening Service Market Size Market Share by Type (2018-2023)
  • 2.4 Genetic Carrier Screening Service Segment by Application
    • 2.4.1 Pregnant Woman
    • 2.4.2 Couple
  • 2.5 Genetic Carrier Screening Service Market Size by Application
    • 2.5.1 Genetic Carrier Screening Service Market Size CAGR by Application (2018 VS 2022 VS 2029)
    • 2.5.2 Global Genetic Carrier Screening Service Market Size Market Share by Application (2018-2023)

3 Genetic Carrier Screening Service Market Size by Player

  • 3.1 Genetic Carrier Screening Service Market Size Market Share by Players
    • 3.1.1 Global Genetic Carrier Screening Service Revenue by Players (2018-2023)
    • 3.1.2 Global Genetic Carrier Screening Service Revenue Market Share by Players (2018-2023)
  • 3.2 Global Genetic Carrier Screening Service Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Genetic Carrier Screening Service by Regions

  • 4.1 Genetic Carrier Screening Service Market Size by Regions (2018-2023)
  • 4.2 Americas Genetic Carrier Screening Service Market Size Growth (2018-2023)
  • 4.3 APAC Genetic Carrier Screening Service Market Size Growth (2018-2023)
  • 4.4 Europe Genetic Carrier Screening Service Market Size Growth (2018-2023)
  • 4.5 Middle East & Africa Genetic Carrier Screening Service Market Size Growth (2018-2023)

5 Americas

  • 5.1 Americas Genetic Carrier Screening Service Market Size by Country (2018-2023)
  • 5.2 Americas Genetic Carrier Screening Service Market Size by Type (2018-2023)
  • 5.3 Americas Genetic Carrier Screening Service Market Size by Application (2018-2023)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Genetic Carrier Screening Service Market Size by Region (2018-2023)
  • 6.2 APAC Genetic Carrier Screening Service Market Size by Type (2018-2023)
  • 6.3 APAC Genetic Carrier Screening Service Market Size by Application (2018-2023)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Genetic Carrier Screening Service by Country (2018-2023)
  • 7.2 Europe Genetic Carrier Screening Service Market Size by Type (2018-2023)
  • 7.3 Europe Genetic Carrier Screening Service Market Size by Application (2018-2023)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Genetic Carrier Screening Service by Region (2018-2023)
  • 8.2 Middle East & Africa Genetic Carrier Screening Service Market Size by Type (2018-2023)
  • 8.3 Middle East & Africa Genetic Carrier Screening Service Market Size by Application (2018-2023)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Genetic Carrier Screening Service Market Forecast

  • 10.1 Global Genetic Carrier Screening Service Forecast by Regions (2024-2029)
    • 10.1.1 Global Genetic Carrier Screening Service Forecast by Regions (2024-2029)
    • 10.1.2 Americas Genetic Carrier Screening Service Forecast
    • 10.1.3 APAC Genetic Carrier Screening Service Forecast
    • 10.1.4 Europe Genetic Carrier Screening Service Forecast
    • 10.1.5 Middle East & Africa Genetic Carrier Screening Service Forecast
  • 10.2 Americas Genetic Carrier Screening Service Forecast by Country (2024-2029)
    • 10.2.1 United States Genetic Carrier Screening Service Market Forecast
    • 10.2.2 Canada Genetic Carrier Screening Service Market Forecast
    • 10.2.3 Mexico Genetic Carrier Screening Service Market Forecast
    • 10.2.4 Brazil Genetic Carrier Screening Service Market Forecast
  • 10.3 APAC Genetic Carrier Screening Service Forecast by Region (2024-2029)
    • 10.3.1 China Genetic Carrier Screening Service Market Forecast
    • 10.3.2 Japan Genetic Carrier Screening Service Market Forecast
    • 10.3.3 Korea Genetic Carrier Screening Service Market Forecast
    • 10.3.4 Southeast Asia Genetic Carrier Screening Service Market Forecast
    • 10.3.5 India Genetic Carrier Screening Service Market Forecast
    • 10.3.6 Australia Genetic Carrier Screening Service Market Forecast
  • 10.4 Europe Genetic Carrier Screening Service Forecast by Country (2024-2029)
    • 10.4.1 Germany Genetic Carrier Screening Service Market Forecast
    • 10.4.2 France Genetic Carrier Screening Service Market Forecast
    • 10.4.3 UK Genetic Carrier Screening Service Market Forecast
    • 10.4.4 Italy Genetic Carrier Screening Service Market Forecast
    • 10.4.5 Russia Genetic Carrier Screening Service Market Forecast
  • 10.5 Middle East & Africa Genetic Carrier Screening Service Forecast by Region (2024-2029)
    • 10.5.1 Egypt Genetic Carrier Screening Service Market Forecast
    • 10.5.2 South Africa Genetic Carrier Screening Service Market Forecast
    • 10.5.3 Israel Genetic Carrier Screening Service Market Forecast
    • 10.5.4 Turkey Genetic Carrier Screening Service Market Forecast
    • 10.5.5 GCC Countries Genetic Carrier Screening Service Market Forecast
  • 10.6 Global Genetic Carrier Screening Service Forecast by Type (2024-2029)
  • 10.7 Global Genetic Carrier Screening Service Forecast by Application (2024-2029)

11 Key Players Analysis

  • 11.1 Clinical Labs
    • 11.1.1 Clinical Labs Company Information
    • 11.1.2 Clinical Labs Genetic Carrier Screening Service Product Offered
    • 11.1.3 Clinical Labs Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.1.4 Clinical Labs Main Business Overview
    • 11.1.5 Clinical Labs Latest Developments
  • 11.2 Eurofins Scientific
    • 11.2.1 Eurofins Scientific Company Information
    • 11.2.2 Eurofins Scientific Genetic Carrier Screening Service Product Offered
    • 11.2.3 Eurofins Scientific Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.2.4 Eurofins Scientific Main Business Overview
    • 11.2.5 Eurofins Scientific Latest Developments
  • 11.3 Fulgent Genetics
    • 11.3.1 Fulgent Genetics Company Information
    • 11.3.2 Fulgent Genetics Genetic Carrier Screening Service Product Offered
    • 11.3.3 Fulgent Genetics Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.3.4 Fulgent Genetics Main Business Overview
    • 11.3.5 Fulgent Genetics Latest Developments
  • 11.4 Gene by Gene
    • 11.4.1 Gene by Gene Company Information
    • 11.4.2 Gene by Gene Genetic Carrier Screening Service Product Offered
    • 11.4.3 Gene by Gene Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.4.4 Gene by Gene Main Business Overview
    • 11.4.5 Gene by Gene Latest Developments
  • 11.5 Illumina
    • 11.5.1 Illumina Company Information
    • 11.5.2 Illumina Genetic Carrier Screening Service Product Offered
    • 11.5.3 Illumina Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.5.4 Illumina Main Business Overview
    • 11.5.5 Illumina Latest Developments
  • 11.6 Invitae
    • 11.6.1 Invitae Company Information
    • 11.6.2 Invitae Genetic Carrier Screening Service Product Offered
    • 11.6.3 Invitae Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.6.4 Invitae Main Business Overview
    • 11.6.5 Invitae Latest Developments
  • 11.7 MedGenome Labs
    • 11.7.1 MedGenome Labs Company Information
    • 11.7.2 MedGenome Labs Genetic Carrier Screening Service Product Offered
    • 11.7.3 MedGenome Labs Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.7.4 MedGenome Labs Main Business Overview
    • 11.7.5 MedGenome Labs Latest Developments
  • 11.8 My Baby Company
    • 11.8.1 My Baby Company Company Information
    • 11.8.2 My Baby Company Genetic Carrier Screening Service Product Offered
    • 11.8.3 My Baby Company Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.8.4 My Baby Company Main Business Overview
    • 11.8.5 My Baby Company Latest Developments
  • 11.9 Myriad Genetics
    • 11.9.1 Myriad Genetics Company Information
    • 11.9.2 Myriad Genetics Genetic Carrier Screening Service Product Offered
    • 11.9.3 Myriad Genetics Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.9.4 Myriad Genetics Main Business Overview
    • 11.9.5 Myriad Genetics Latest Developments
  • 11.10 Natera
    • 11.10.1 Natera Company Information
    • 11.10.2 Natera Genetic Carrier Screening Service Product Offered
    • 11.10.3 Natera Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.10.4 Natera Main Business Overview
    • 11.10.5 Natera Latest Developments
  • 11.11 NxGen MDx, LLC
    • 11.11.1 NxGen MDx, LLC Company Information
    • 11.11.2 NxGen MDx, LLC Genetic Carrier Screening Service Product Offered
    • 11.11.3 NxGen MDx, LLC Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.11.4 NxGen MDx, LLC Main Business Overview
    • 11.11.5 NxGen MDx, LLC Latest Developments
  • 11.12 OPKO Health
    • 11.12.1 OPKO Health Company Information
    • 11.12.2 OPKO Health Genetic Carrier Screening Service Product Offered
    • 11.12.3 OPKO Health Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.12.4 OPKO Health Main Business Overview
    • 11.12.5 OPKO Health Latest Developments
  • 11.13 Thermo Fisher Scientific
    • 11.13.1 Thermo Fisher Scientific Company Information
    • 11.13.2 Thermo Fisher Scientific Genetic Carrier Screening Service Product Offered
    • 11.13.3 Thermo Fisher Scientific Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.13.4 Thermo Fisher Scientific Main Business Overview
    • 11.13.5 Thermo Fisher Scientific Latest Developments
  • 11.14 Sonic Genetics
    • 11.14.1 Sonic Genetics Company Information
    • 11.14.2 Sonic Genetics Genetic Carrier Screening Service Product Offered
    • 11.14.3 Sonic Genetics Genetic Carrier Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 11.14.4 Sonic Genetics Main Business Overview
    • 11.14.5 Sonic Genetics Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Genetic Carrier Screening Service. Industry analysis & Market Report on Genetic Carrier Screening Service is a syndicated market report, published as Global Genetic Carrier Screening Service Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Genetic Carrier Screening Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,920.68
5,841.36
3,414.78
6,829.56
562,761.60
1,125,523.20
305,463.60
610,927.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report